Novel Liver-Targeting Drug Offers Hope for AAT Deficiency Novel Liver-Targeting Drug Offers Hope for AAT Deficiency

The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.Medscape Medical News

Source: Medscape Gastroenterology Headlines - June 28, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news